News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,406 signal articles · 542 in last 24h · 104,580 total before filter · latest 15m ago

542last 24h

2529last 7d

484● bullish (7d)

255● bearish (7d)

198publishers

All Macro195 Earnings1546 M&A142 Regulatory16 Product7 Analyst28

✕ clear all filtersticker: RXRXSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Insider Monkey75d agoneutral

Morgan Stanley Raises its Price Target on Recursion (RXRX)

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) to $5.50 from $5 and kept an Equal Weight rating on the shares. On May 6, 2026, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported […]

RXRX